Abstract
Get full access to this article
View all access options for this article.
References
1.
Bluebird
Bio
.
Bluebird bio Reports Second Quarter Financial Results and Provides Operational
Update
. August 9, 2021. https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-reports-second-quarter-financial-results-and (last accessed
August 9 , 2021
).
2.
Cytiva and Pall Corp
. Cytiva and Pall Corporation investing 1.5 billion USD over two years to meet growing demand for biotechnology solutions. July 27, 2021. https://www.cytivalifesciences.com/en/us/news-center/investing-for-capacity-expansion-2021-10001 (last accessed
August 8 , 2021
).
3.
Philippidis
A
. Danaher Delivers: Cytiva Pall Plan $1.5B manufacturing expansion. Genetic Engineering & Biotechnology News. August 2, 2021. https://www.genengnews.com/gen-edge/danaher-delivers-cytiva-pall-plan-1-5b-manufacturing-expansion/ (last accessed
August 8 , 2021
).
4.
Moderna INC (MRNA)
. Q2 2021 Earnings Call Transcript. The Motley Fool. August 5, 2021. https://www.fool.com/earnings/call-transcripts/2021/08/05/moderna-inc-mrna-q2-2021-earnings-call-transcript/ (last accessed
August 12 , 2021
).
5.
The Motley Fool
. Moderna INC (MRNA) Q2 2021 Earnings Call Transcript. August 5, 2021. https://www.fool.com/earnings/call-transcripts/2021/08/05/moderna-inc-mrna-q2-2021-earnings-call-transcript/ (last accessed
August 27 , 2021
).
6.
Shape Therapeutics
. Shape Therapeutics secures $112 million in Series B financing to advance breakthrough RNA Technology platforms to democratize gene therapy. July 15, 2021. https://www.globenewswire.com/news-release/2021/07/15/2263498/0/en/Shape-Therapeutics-Secures-112-Million-in-Series-B-Financing-to-Advance-Breakthrough-RNA-Technology-Platforms-to-Democratize-Gene-Therapy.html (last accessed
August 8 , 2021
).
7.
Ring Therapeutics
. Ring therapeutics raises $117 million in Series B funding to expand novel vector platform to unlock the full potential of gene therapy. July 28, 2021. https://www.prnewswire.com/news-releases/ring-therapeutics-raises-117-million-in-series-b-funding-to-expand-novel-vector-platform-to-unlock-the-full-potential-of-gene-therapy-301342708.html (last accessed
August 8 , 2021
).
8.
U.S. Securities and Exchange Commission
. Form S-1 Registration Statement of Castle Creek Biosciences. Filed July 16, 2021. https://www.sec.gov/Archives/edgar/data/0001756702/000119312521217390/d167954ds1.htm (last accessed
August 12 , 2021
).
9.
Sana Biotechnology
. Sana Biotechnology enters long-term lease to establish manufacturing facility to enable its gene and cell therapy product candidates. July 14, 2021. https://ir.sana.com/news-releases/news-release-details/sana-biotechnology-enters-long-term-lease-establish (last accessed
August 8 , 2021
).